Taiwan FDA recalls tainted sartan blood pressure medicine by Sanofi

Three types of sartan high blood pressure medicine produced by French pharmaceutical maker Sanofi were ordered on Monday to be recalled after being found to contain a potential carcinogen, according to Taiwan's Food and Drug Administration (FDA).

(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)